Bayer fell around 20% after it stopped a late-stage study for a cardiovascular drug early due to lack of efficacy and was ordered to pay around $1.6 billion in a lawsuit relating to its Roundup weedkiller.
from WSJ.com: World News https://ift.tt/fP5CDwn
Bayer Tumbles After Clinical Trial Failure, Roundup Case Loss
November 20, 2023
0
